Tuesday Aug 26
Metabolix Closes $25 Million Private Placement
Proceeds from this transaction will be used to continue executing the Company's business plan, including its efforts to secure intermediate production capacity, build relationships with key customers and intensify the Company's focus on application and product development for Metabolix PHA specialty biopolymers.
METABOLIX, INC. FILES (8-K) Disclosing Regulation FD Disclosure,...
A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 7.01.
Metabolix, Inc. Announces Second Quarter 2014 Financial Results
Assuming we get the NASDAQ exception, we plan to deploy this capital to continue executing our business plan and building an intermediate-scale specialty polymers business based on our PHA biopolymer additives, that will serve as the foundation for our longer-range plans and the future growth of our business," said "Operationally, we made good ... (more)
Metabolix, Inc. Enters Into Private Placement Agreement With...
At closing, the investors will purchase an aggregate of 50 million units of the Company's securities at a price of per unit.